Cargando…
Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial
OBJECTIVE: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial reported no differences in most cardiovascular disease (CVD) outcomes between intensive and standard blood pressure therapy in individuals with diabetes mellitus (DM) and hypertension. Many such individual...
Autores principales: | Barzilay, Joshua I., Howard, Annie G., Evans, Gregory W., Fleg, Jerome L., Cohen, Robert M., Booth, Gillian L., Kimel, Angela R., Pedley, Carolyn F., Cushman, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379577/ https://www.ncbi.nlm.nih.gov/pubmed/22723577 http://dx.doi.org/10.2337/dc11-1827 |
Ejemplares similares
-
Restricted Mean Survival Time in Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure
por: Shi, Sandra, et al.
Publicado: (2020) -
Blood-Pressure Variation and Cardiovascular Changes in Diabetes Mellitus
por: Chakravarti, Amal
Publicado: (1945) -
Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
por: Pop-Busui, Rodica, et al.
Publicado: (2010) -
Comparison of ambulatory blood pressure and clinic blood pressure in relation to cardiovascular diseases in diabetic patients
por: Shen, Jian, et al.
Publicado: (2017) -
Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Huang, Chenxi, et al.
Publicado: (2017)